These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21050857)

  • 1. A2b adenosine receptors in cardioprotection: timing is everything.
    Methner C; Krieg T
    J Mol Cell Cardiol; 2011 Mar; 50(3):582-3. PubMed ID: 21050857
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.
    Eckle T; Krahn T; Grenz A; Köhler D; Mittelbronn M; Ledent C; Jacobson MA; Osswald H; Thompson LF; Unertl K; Eltzschig HK
    Circulation; 2007 Mar; 115(12):1581-90. PubMed ID: 17353435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury.
    Hart ML; Jacobi B; Schittenhelm J; Henn M; Eltzschig HK
    J Immunol; 2009 Apr; 182(7):3965-8. PubMed ID: 19299692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning.
    Teoh N; Leclercq I; Pena AD; Farrell G
    Hepatology; 2003 Jan; 37(1):118-28. PubMed ID: 12500196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
    Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ
    Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine: trigger and mediator of cardioprotection.
    Cohen MV; Downey JM
    Basic Res Cardiol; 2008 May; 103(3):203-15. PubMed ID: 17999026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Tissue-Specific Function of Adora2b in Cardioprotection.
    Seo SW; Koeppen M; Bonney S; Gobel M; Thayer M; Harter PN; Ravid K; Eltzschig HK; Mittelbronn M; Walker L; Eckle T
    J Immunol; 2015 Aug; 195(4):1732-43. PubMed ID: 26136425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IB-MECA and cardioprotection.
    Xu Z; Jang Y; Mueller RA; Norfleet EA
    Cardiovasc Drug Rev; 2006; 24(3-4):227-38. PubMed ID: 17214599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cyclic adenosine diphosphoribose receptor activation in ischemic preconditioning induced protection in mouse brain.
    Rehni AK; Singh TG; Bhateja P; Singh N; Arora S
    Brain Res; 2010 Jan; 1309():75-82. PubMed ID: 19896931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remote ischemic preconditioning].
    Maslov LN; Kolar F; Krieg T
    Usp Fiziol Nauk; 2009; 40(4):64-78. PubMed ID: 19886189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metallothionein mediates cardioprotection induced by delayed preconditioning with adenosine A1 receptor agonist in rabbits].
    Xie C; Ran K; Liu J; Xu J; Chang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 34(7):603-7. PubMed ID: 19648671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we putting too much stock in mice?
    Auchampach JA; Maas JE; Wan TC; Figler RA; Gross GJ
    J Mol Cell Cardiol; 2011 Mar; 50(3):584-5. PubMed ID: 21129379
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning.
    Matsumoto T; O'Malley K; Efron PA; Burger C; McAuliffe PF; Scumpia PO; Uchida T; Tschoeke SK; Fujita S; Moldawer LL; Hemming AW; Foley DP
    Surgery; 2006 Nov; 140(5):793-802. PubMed ID: 17084723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice.
    Teoh N; Field J; Farrell G
    J Hepatol; 2006 Jul; 45(1):20-7. PubMed ID: 16600417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined morphine and limb remote ischaemia postconditioning may produce an enhanced cardioprotection.
    Xu YC; Xue FS; Liao X; Xiong J; Yang QY; Wang WL; Zhang YM
    Med Hypotheses; 2009 Sep; 73(3):302-5. PubMed ID: 19428190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local stimulation of the adenosine A2B receptors induces an increased release of IL-6 in mouse striatum: an in vivo microdialysis study.
    Vazquez JF; Clement HW; Sommer O; Schulz E; van Calker D
    J Neurochem; 2008 May; 105(3):904-9. PubMed ID: 18088370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteins released from liver after ischaemia induced an elevation of heart resistance against ischaemia-reperfusion injury: 2. Beneficial effect of liver ischaemia in situ.
    Barteková M; Sulová Z; Pancza D; Ravingerová T; Stankovicová T; Styk J; Breier A
    Gen Physiol Biophys; 2004 Dec; 23(4):489-97. PubMed ID: 15815082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.